WIF-1 GENE METHYLATION IN CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS Article Sukhikh G.T., Ashrafyan L.A., Bairamova G.R., Babkina I.O., Chernova V.F., Osipyants A.I., Korolkova A.I., Poloznikov A.A., Asfarova G.R., Mullabaeva S.M., Kogan E.A., Muizhnek E.L., Drukh V.M., Kiselev V.I. Akusherstvo i Ginekologiya. ООО «Бионика Медиа». 2017. P. 114-123
FIRST RESULTS OF THE DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL OF DIM-BASED THERAPY DESIGNED AS PERSONALIZED APPROACH TO REVERSE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) Article Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I., Andrianova E., Baranovskiy P. EPMA Journal. BioMed Central Ltd.. Vol. 7. 2016.
DOUBLE-BLIND RANDOMIZED PLACEBOCONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION Article Ashrafian L., Sukhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E. EPMA Journal. BioMed Central Ltd.. Vol. 6. 2015.
DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION Article Ashrafian L., Suhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E. EPMA Journal. BioMed Central Ltd.. Vol. Vol625. 2015.
PHARMACOKINETIC STUDY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN FEMALE PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA Article Andrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I. Biology and Medicine. AstonJournals. Vol. Vol7. 2015.
STUDY TO ASSESS SAFETY AND TOLERABILITY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA Article Andrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I. Biology and Medicine. AstonJournals. Vol. Vol7. 2015.
PRECLINICAL ANTITUMOR ACTIVITY OF THE DIINDOLYLMETHANE FORMULATION IN XENOGRAFT MOUSE MODEL OF PROSTATE CANCER Article Kiselev V.I., Drukh V.M., Muyzhnek E.L., Kuznetsov I.N., Pchelintseva O.I., Paltsev M.A. Experimental Oncology. Morion LLC. Vol. 36. 2014. P. 90-93
SAFETY AND TOLERABILITY OF DIM-BASED THERAPY DESIGNED AS PERSONALIZED APPROACH TO REVERSE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) Article Paltsev M., Kiselev V., Muyzhnek E., Drukh V., Kuznetsov I., Pchelintseva O. EPMA Journal. BioMed Central Ltd.. Vol. 5. 2014.